Ranbaxy Drugs Limited - Company Profile

It is a pharma public limited company based in Vadodara, Gujarat, India, established in 1984.
1984 Vadodara, Gujarat, India Amalgamated
Last Updated:
Access Report
About Ranbaxy Drugs Limited

Ranbaxy Drugs Limited, a amalgamated public limited company, was established on 31 January 1984 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232GJ1984PLC095288. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹100.05 Cr and a paid-up capital of ₹3.10 Cr.

Its leadership includes Meetal Sharad Sampat (Director), Sanjay Jerry (Director), Sandeep Mehandroo (Director). Past directors included Yogesh Kumar Sareen, Meetal Sharad Sampat, Arun Sawhney. Its latest AGM occurred on 07 August 2017, with the balance sheet filed on 31 March 2017. It is based at Sparc Tandalja, Vadodara, Gujarat, 390020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232GJ1984PLC095288

  • Registration Number

    095288

  • Incorporation Date

    31 January 1984

  • Authorized Capital

    ₹100.05 Cr

  • Paid-Up Capital

    ₹3.10 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 100.05 Cr
  • Paid Up Capital ₹ 3.10 Cr
  • Company Age 42 Year, 22 Days
  • Last Filing with ROC 31 Mar 2017
Company report

Ranbaxy Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ranbaxy Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ranbaxy Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Meetal Sharad Sampat Director 31 Aug 2015 Current
Sanjay Jerry Director 07 Mar 2014 Current
Sandeep Mehandroo Director 04 Apr 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Feb 2008 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Director 24 Jun 2010 Past
Pramod Abcsdd Additional Director 31 Aug 2015 Past
Pramod Abcsdd Key Managerial Personnel - Past
Pramod Abcsdd Director 03 Mar 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ranbaxy Drugs.

Ranbaxy Drugs Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Ranbaxy Drugs revenue growth over time
Ranbaxy Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ranbaxy Drugs?

In 2017, Ranbaxy Drugs had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ranbaxy Drugs?

Unlock and access historical data on people associated with Ranbaxy Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ranbaxy Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranbaxy Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ranbaxy Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Ranbaxy Drugs Limited last Annual general meeting of members was held on 07 Aug 2017 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Ranbaxy Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Ahmedabad. was completed.

  • Director Appointment

    Meetal Sharad Sampat was appointed as a Director was appointed as a Director on 31 Aug 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.

  • Director Appointment

    Sanjay Jerry was appointed as a Director was appointed as a Director on 07 Mar 2014 & has been associated with this company since 11 years 11 months . was recorded as a recent event.

  • Director Appointment

    Progress on Sandeep Mehandroo was appointed as a Director was appointed as a Director on 04 Apr 2008 & has been associated with this company since 17 years 10 months . was documented.

  • Company Incorporation

    The activity Ranbaxy Drugs Limited was registered on 31 Jan 1984 with Roc Ahmedabad & aged 42 years 22 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ranbaxy Drugs Limited?

The CIN of Ranbaxy Drugs Limited is U24232GJ1984PLC095288.

Where is Ranbaxy Drugs Limited headquartered?

Ranbaxy Drugs Limited is headquartered at Sparc Tandalja, Vadodara, Gujarat, 390020.

When was Ranbaxy Drugs Limited incorporated?

Ranbaxy Drugs Limited was incorporated on 31 January 1984.

Who are the current directors of Ranbaxy Drugs Limited?

The current directors of Ranbaxy Drugs Limited are

What is the primary industry of Ranbaxy Drugs Limited?

The primary industry of Ranbaxy Drugs Limited is Pharma.

Is Ranbaxy Drugs Limited a listed company?

Ranbaxy Drugs Limited is unlisted.

What is the capital structure of Ranbaxy Drugs Limited?

The authorized capital of Ranbaxy Drugs Limited is ₹100.05 Cr, and the paid-up capital is ₹3.10 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available